|
|
|
| Webinar: Planning For Scale From The Start: Where Early Development Decisions Create Commercial Risk | Commercialization challenges often start long before commercial manufacturing. This Catalent webinar explores how emerging biopharma companies can connect development, manufacturing, quality, and supply planning earlier to prepare for future demand, reduce scale-up and technology transfer risk, and strengthen launch readiness. Learn how an accelerated, connected approach can build greater supply resilience as programs progress toward commercialization. Click here to learn more. |
|
|
|
Webinar | Abzena | Selecting the right cell line platform is complex. Learn how flexible strategies, integrated technologies, and expert workflows enable high productivity, rapid timelines, and a de-risked path to clinical success. |
|
|
|
Webinar | KBI Biopharma | See real-world case studies showing how advanced characterization analytics and mass spectrometry resolve protein quality issues, prevent costly delays, and reduce risk across the lifecycle. |
|
|
|
Video | Adare Pharma Solutions | Join Dr. Srinivasan Shanmugam in this webinar to learn key strategies for selecting the right CDMO, reducing costs, accelerating timelines, and ensuring product success. |
|
|
|
Video | West Pharmaceutical Services, Inc. | True Annex 1 compliance requires a facility-wide contamination-control culture. Discover how rigorous risk awareness shapes behavior at every touchpoint across a manufacturing environment. |
|
|
|
Video | Life Science Leader | On this week's episode of the Business of Biotech, Omar Khalil, Managing Director at Santé Ventures, describes forming and funding startups and early-stage biotech companies with a focus on clinical data and differentiation as the key value drivers. |
|
|
|
Video | Lonza | Bingnan Gu, Head of Viral Vector R&D, shares how the company is helping developers turn complex in vivo LVV designs into clinical-ready products, and see the new analytics that reveal what’s really inside your vector. |
|
|
|
Video | Sanisure | Dedicated fill lines for each needle eliminate the need to perform line splitting, minimizing the risk of fluid-path bottlenecks, cavitation for sensitive drug products, and structural weak points in assembly integrity. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
